ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6  (03-2018)

Period of time： 2018年6期

Publisher： John Wiley & Sons Inc

Founded in： 1987

Total resources： 82

E-ISSN： 1365-2036|47|6

ISSN： 0269-2813

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6

Menu

Issue Information

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 701-703

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Systematic review with meta‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patients

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 704-714

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Systematic review: psychosocial factors associated with pain in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 715-729

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 730-737

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 738-752

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 753-762

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 763-772

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 773-783

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 784-791

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Use of olmesartan and enteropathy outcomes: a multi‐database study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS,volume 47,issue 6 , Vol. 47, Iss. 6, 2018-03 , pp. 792-800

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 Next Display item(s) per page Total 31 item(s)